COMMUNIQUÉS West-GlobeNewswire

Oculis Reports Q1 2026 Financial Results and Provides Company Update
11/05/2026
Pipeline Advancing as Planned, Leading with OCS-01 Key Milestone Completion of LPLV in Both DIAMOND Phase 3 Trials; Data Readout on Track for June 2026 Licaminlimab PREDICT-1 Trial in Active Site Recruitment Phase, [...]
BioCardia to Host Q1 2026 Financial Results and Corporate Update Conference Call on May 15, 2026
11/05/2026
SUNNYVALE, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- BioCardia ® , Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced it [...]
Aktis Oncology Reports Financial Results and Business Highlights for First Quarter 2026
11/05/2026
Announced two-trial clinical development strategy for AKY-2519 enabling evaluation in multiple patient segments Initiated Phase 1b clinical trial of AKY-2519 in metastatic castration-resistant prostate cancer (mCRPC); [...]
MacroGenics to Sell GMP Manufacturing Operations to Bora Pharmaceuticals
11/05/2026
•MacroGenics to receive $122.5 million upfront payment from Bora upon closing •Transaction includes transfer of manufacturing site, CDMO operations and associated personnel to Bora ROCKVILLE, MD, May 11, 2026 (GLOBE [...]
SCYNEXIS Reports First Quarter 2026 Financial Results and Provides Corporate Update
11/05/2026
Completed transformative acquisition of PXL-770, (now SCY-770), an innovative, highly selective, direct AMPK activator for the treatment of autosomal dominant polycystic kidney disease (ADPKD) A Phase 2 proof-of-concept [...]
CORRECTION – Human Appeal Launches Hajj Step Challenge, Turning Steps into a Lifeline
11/05/2026
Participants challenged to walk 10,000 steps a day during the 10 most sacred days of the Islamic Calendar, raising funds to deliver vital meals to those in need In a release issued earlier on Monday, May 11, under the [...]
Pharvaris Announces Closing of $132.3 Million Underwritten Offering of Ordinary Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares
11/05/2026
ZUG, Switzerland, May 11, 2026 (GLOBE NEWSWIRE) -- Pharvaris N.V. (“Pharvaris,” Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs [...]
Sotera Health Announces Secondary Offering of Common Stock
11/05/2026
CLEVELAND, May 11, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC) (the “Company”) today announced the launch of a secondary offering (the “Offering”) of 31,838,253 shares of its common stock, par value $0. [...]
Catalyst Pharmaceuticals Reports First Quarter 2026 Financial Results
11/05/2026
Delivered Q1 2026 Total Revenues of $149.4 Million Results include 28% YoY Increase in Net Product Revenues from FIRDAPSE® & AGAMREE® Reported Cash and Cash Equivalents of $755.9 Million and No Funded Debt as of [...]
STERIS Announces Financial Results for Fiscal 2026 Fourth Quarter and Full Year
11/05/2026
Full year fiscal 2026 revenue from continuing operations increased 9%; constant currency organic revenue growth was 7% Full year fiscal 2026 as reported diluted EPS from continuing operations increased to $7.93; [...]
Cellectis Reports Financial Results for the First Quarter 2026
11/05/2026
Pivotal Phase 2 with lasme-cel in r/r B-ALL (BALLI-01 trial) Pivotal Phase 2 first interim analysis expected in Q4 2026 BLA submission anticipated in 2028 Phase 1 with eti-cel in r/r NHL (NATHALI-01 trial) Full Phase 1 [...]
FDA Advances Drug Repurposing to Address Unmet Medical Needs
11/05/2026
Agency is particularly focused on new uses to treat chronic or rare diseases White Oak, Md., May 11, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration today announced it is soliciting input on efforts with [...]
Solana Company to Release First Quarter 2026 Operating Results on May 15, 2026
11/05/2026
NEWTOWN, Pa., May 11, 2026 (GLOBE NEWSWIRE) -- Solana Company (NASDAQ: HSDT) (the “Company” or “HSDT”), a publicly listed company, today announced that the Company will release its first quarter operating results on [...]
SI-BONE, Inc. Reports Financial Results for the First Quarter 2026 and Raises 2026 Guidance
11/05/2026
Delivered ~11% worldwide revenue growth, record physician engagement and ~440% improvement in adjusted EBITDA First Quarter 2026 Financial Highlights (all comparisons are to the prior year period) Worldwide revenue of $ [...]
Cellectis publie ses résultats financiers du premier trimestre 2026
11/05/2026
Phase 2 pivot évaluant lasmé-cel dans la LAL-B en rechute ou réfractaire (étude BALLI-01) Analyse intermédiaire de phase 2 pivot attendue en Q4 2026 Dépôt de demande d'autorisation de mise sur le marché (BLA) prévu en [...]
Sanara MedTech Inc. Reports First Quarter 2026 Financial Results (Unaudited)
11/05/2026
Net Revenue Growth of 19% and Net Profitability from Continuing Operations of $0.04 Per Fully Diluted Share for the Quarter FORT WORTH, TX, May 11, 2026 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” “Sanara MedTech [...]
Coherus Oncology Reports First Quarter 2026 Financial Results and Provides Business Update
11/05/2026
– LOQTORZI ® net revenue of $11.8 million in Q1 2026 – – Patient accrual complete for 1L HCC Phase 2 randomized clinical trial for anti-IL27 casdozokitug, timing for data readouts tracking to projections – – Tagmokitug [...]
Tonix Pharmaceuticals Reports First Quarter 2026 Financial Results and Operational Highlights
11/05/2026
In the first full quarter since launch, 2,145 healthcare providers prescribed TONMYA ® , 3,588 patients initiated treatment, and ~5,400 prescriptions were filled Agreement signed in May with leading group purchasing [...]
CG Oncology’s Presence at American Urological Association (AUA) Annual Meeting Underscores its Strong Commitment to NMIBC
11/05/2026
- First results from CORE-008 Cohort CX Phase 2 Trial evaluating intravesical combination therapy in High-Risk BCG-Exposed and BCG-Unresponsive patients to be presented - - Visit CG Oncology at booth #3051 - DALLAS, May [...]

Pages